<DOC>
	<DOCNO>NCT00134199</DOCNO>
	<brief_summary>To evaluate effect 6-month administration CP-945,598 : - weight loss waist circumference , - blood pressure , cholesterol , glucose - biochemical variable like insulin , leptin , ghrelin , adiponectin , PAI 1 , TNF-Î± hsCRP - relationship concentration drug blood parameter - physical psychosocial functioning , weight relate symptom , treatment satisfaction , appetite/hunger/satiety/craving mood , anxiety , anhedonia depression</brief_summary>
	<brief_title>A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Sibutramine</mesh_term>
	<criteria>Male and/or female subject without clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test Body Mass Index ( BMI ) Â³30 &lt; 40 kg/m2 , subject additional co morbidity ; BMI Â³27 kg/m2 &lt; 40 kg/m2 , subject co morbidity [ history essential hypertension and/or dyslipidemia define high LDL ( Â³160 mg/dL ) high total cholesterol ( Â³240 mg/dL ) ] ; Subjects rest sit systolic blood pressure 140 mmHg great diastolic blood pressure 90 mmHg great . Subjects type 2 diabetes fast blood glucose concentration Â³126 mg/dL ; Subjects history eat disorder like anorexia nervosa bulimia nervosa Subjects prescription nonprescription appetite weight modify drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2006</verification_date>
</DOC>